JCP reached new 52 week lows today and is finally immediate-term TRADE oversold just 2 days prior to the 1 year anniversary of JCP’s biggest hire in history.
With the seismic shift in JCP’s pricing strategy that has left consumers scratching their heads coupled with underappreciated capital investment required to ultimately bring RJ’s vision to life, there’s little to support the stock here over the intermediate-term. It will likely be a while, perhaps a long while, before we revisit the $29.92 strike price at which RJ’s warrants are struck. Lucky for him, he has 5-years to get there. Unfortunately, investors typically operate under a far different duration.
Today, we wouldn't touch it on the long side until it is a mid-teenager.
get free cartoon of the day!
Start receiving Hedgeye's Cartoon of the Day, an exclusive and humourous take on the market and the economy, delivered every morning to your inbox
By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails.
Starbucks seems to be acutely aware of past mistakes and we do not expect management to repeat the mistakes that brought the stock under $10 in 2009. We would not advise buying the stock at this point, however, given that the Street is likely too bullish on EPS for 2HFY12. The longer-term story for Starbucks remains one of the very best in the space but the likely impact of near-term headwinds leads us to look elsewhere over the TRADE (three weeks or less) and TREND (three months or more) durations.
Starbucks CFO Troy Alstead took the stage today at the William Blair Growth Stock Conference. Below are the primary takeaways of the presentation:
- The company now expects $0.44-0.45 EPS in 3QFY12 and $0.46-0.47 EPS in 4QFY12 versus prior guidance of $0.45-0.46 and $0.46-0.48, respectively. The Street, according to Bloomberg, is expecting $0.46 and $0.49 EPS in 3QFY12 and 4QFY12, respectively. The revision in guidance is due to costs associated with the Bay Bread LLC acquisition. Overall, the La Boulange acquisition will be $0.02 dilutive to FY12 EPS and will also dilute FY13 EPS.
- Investing in La Boulange and Evolution Fresh is going to be a headwind to EPS going forward; there is a potential for capital needs to come in larger than expected given the distribution capabilities that need to be built out to cater for both brands on a national basis.
- Starbucks see continuing weakness in the EMEA division.
- Coffee is expected to be a tailwind in FY13
We would not advise clients to buy this stock at this point in time. We have liked the name for over three years but believe that sentiment has gotten ahead of the fundamental outlook of the company. Company guidance is indicating that estimates are too high for FY12 and increasing economic uncertainty in Europe could cause actual earnings to come in even lower than the guidance is suggesting.
The bulls, Tim Geithner and Barack Obama have all failed us, says Hedgeye CEO Keith McCullough. Bank bailouts don’t bode well for the markets – this is clear. The failed policies of the Federal Reserve and the International Monetary Fund are getting us nowhere. McCullough doesn’t like the bailouts and neither do the markets. But don’t tell Christine Lagarde that.
“At the end of the day you can make mistakes, losers can win and I think the entire general population is sick and tired of it and that’s why there’s outflows out of equities. Markets are going lower, not higher,” says McCullough
Others thought Greece and the uncertainty with the June 17thelections were the market catalyst. That’s great. We’re going to stick to being realists and following the TRADE, TREND and TAIL durations on the S&P 500. Wishful thinking only takes you so far. This is an election year. Does the general public want to follow in the footsteps of Europe? Do they want another Hank Paulson? Not a chance.
daily macro intelligence
Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.